First Successful Haploidentical Stem Cell Transplantation in Romania

1. GYURKOCZA B., REZVANI A., STORB RF. Allogeneic hematopoietic cell transplantation: the state-of-the-art. Expert Rev Hematol. 2010; 3(3):285-99.10.1586/ehm.10.21294339320871781Search in Google Scholar

2. BARON F., STORB R. Allogeneic hematopoietic cell transplantation as treatment for hematological malignancies: a review.Search in Google Scholar

Springer Semin Immunopathol. 2004; 26(1-2):71-94.10.1007/s00281-004-0165-315549304Search in Google Scholar

3. BARONF., STORB R., LITTLE MT. Hematopoietic cell transplantation: five decades of progress. Arch Med Res. 2003; 34(6):528-44.10.1016/j.arcmed.2003.09.01014734093Search in Google Scholar

4. STAAL F.J., BAUM C., COWAN C., DZIERZAK E., HACEIN-BEY-ABINA S., KARLSSON S., et al. Stem cell self-renewal: lessons from bone marrow, gut and iPS toward clinical applications. Leukemia. 2011; 25(7):1095-102.10.1038/leu.2011.5221527933Search in Google Scholar

5. SAULNIER N., DI CAMPLI C., ZOCCO M.A., DI GIOCCHINNO G., NOVI M., GASPARRINI A. From stem cell to solid organ. Bone marrow, peripheral blood or umbilical cord blood as favorable source? Eur Rev Med Pharmacol Sci. 2005; 9(6):315-24.Search in Google Scholar

6. CANELLOS G.P., ANDERSSON J.R., PROPERT K.J., NISSE N., COOPER M.R., HENDERSSON E.S., et al. Chemotherapy of advanced Hodgkin’s disease with MOPP, ABVD, or MOPP alternating with ABVD. N Engl J Med. 1992; 327(21):1478-84.10.1056/NEJM1992111932721021383821Search in Google Scholar

7. DIEHL V., FRANKLIN J., PFEUNDSCHUCH M., LATHAN B., PAULUS U., HASENCLEVER D., et al. Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin’s disease. N Engl J Med. 2003; 348(24):2386-95.10.1056/NEJMoa02247312802024Search in Google Scholar

8. SANTORO A., MAGAGNOLI M., SPINA M., PINOTTI G., SIRACUSANO L., MICHIELI M., et al. Ifosfamide, gemcitabine, and vinorelbine: a new induction regimen for refractory and relapsed Hodgkin’s lymphoma. Haematologica. 2007; 92(1):35-41.10.3324/haematol.1066117229633Search in Google Scholar

9. JOSTING A., RUDOLPH C., MAPARA M., GLOSSMANN J.P., SIENIAWSKI M., SIEBER M., et al. Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin lymphoma: results of a large multicenter study of the German Hodgkin Lymphoma Study Group (GHSG). Ann Oncol. 2005; 16(1):116-23.10.1093/annonc/mdi00315598948Search in Google Scholar

10. GLOSSMANN J.P., STAAK J.O., NOGOVA L., DIEHL V., SCHEID C., KISRO J., et al. Autologous tandem transplantation in patients with primary progressive or relapsed/refractory lymphoma. Ann Hematol. 2005; 84(8):517-25.10.1007/s00277-005-1011-y15759115Search in Google Scholar

11. JOSTING A., NOGOVA L., FRANKLIN J., GLOSSMANN J.P., EICH H.T., SIEBER M., et al. Salvage radiotherapy in patients with relapsed and refractory Hodgkin’s lymphoma: a retrospective analysis from the German Hodgkin Lymphoma Study Group. J ClinOncol. 2005; 23(7):1522-9.10.1200/JCO.2005.05.02215632410Search in Google Scholar

12. SELBY P., PATEL P., MILAN S., MELDRUM M., MANSI J., MBIDDE E., et al. ChlVPP combination chemotherapy for Hodgkin’s disease: long-term results. Br J Cancer. 1990; 62(2):279-85.10.1038/bjc.1990.278Search in Google Scholar

13. POWLES R.L., MORGENSTERN G.R., KAY H.E., MCELWAIN T.J., CLINK H.M., DADY P.J.. et al. Mismatched family donors for bone-marrow transplantation as treatment for acute leukaemia. Lancet. 1983; 1(8325):612-5.10.1016/S0140-6736(83)91793-2Search in Google Scholar

14. BEATTY P.G., CLIFT R.A., MICKELSON E.M., NISPEROS B.B., FLOURNOY N., MARTIN P.J., et al. Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med. 1985; 313(13):765-71.10.1056/NEJM1985092631313013897863Search in Google Scholar

15. BRUNSTEIN C.G.,FUCHS E.J., CARTER S.L., KARANES C., COSTA L.J., WU J., et al. Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts. Blood. 2011; 118(2):282-8.10.1182/blood-2011-03-344853313868321527516Search in Google Scholar

16. AL MALKI M.M., HOROWITZ M., HANDGRETINGER R., LEUNG W., ROY D.C., HUANG X.J., et al. Proceedings from the Second Haploidentical Stem-cell Transplantation Symposium - Haplo2014, San Francisco, California, December 4, 2014. Biol Blood Marrow Transplant. 2016; S1083-8791(16)00004-5.10.1016/j.bbmt.2016.01.001710480526806585Search in Google Scholar

17. KANATE A.S., MUSSETTI A., KHARFAN-DABAJA M.A., AHN K.W., DI GILIO A., BEITINJANEH A., et al. Reducedintensity transplantation for lymphomas using haploidentical related donors versus HLA-matched unrelated donors. Blood. 2016; in press.10.1182/blood-2015-09-671834476009426670632Search in Google Scholar

18. BAYRAKTAR U.D., MILTON D.R., GUINDANI M., RONDON G., CHEN J., AL-ATRASH G., et al. Optimal Threshold and Time of Absolute Lymphocyte Count Assessment for Outcome Prediction after Bone Marrow Transplantation. Biol Blood Marrow Transplant. 2015; S1083-8791(15)00709-0.Search in Google Scholar

19. BRAMMER J.E., KHOURI I., GABALLA S., ANDERLINI P., TOMULEASA C., AHMED S., et al. Outcomes of Haploidentical Stem Cell Transplantation for Lymphoma with Melphalan-Based Conditioning. Biol Blood Marrow Transplant. 2015: S1083-8791(15)00685-0.Search in Google Scholar

20. O’DONNEL P.V., LUZNIK L., JONES R.J., VOGELSANG G.B., LEFFEL M.S., PHELPS M., et al. Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide.Biol Blood Marrow Transplant. 2002; 8(7):377-86.10.1053/bbmt.2002.v8.pm1217148412171484Search in Google Scholar

21. BASHEY A., ZHANG X., SIZEMORE C.A., MANION K., BROWN S., HOLLAND H.K., et al. T-cell-replete HLAhaploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantation. J Clin Oncol. 2013;31(10):1310-6.10.1200/JCO.2012.44.352323423745Search in Google Scholar

22. DI STASI A., MILTON D.R., POON L.M., HAMDI A., RONDON G., CHEN J., et al. Similar transplantation outcomes for acute myeloid leukemia and myelodysplastic syndrome patients with haploidentical versus 10/10 human leukocyte antigenmatched unrelated and related donors. Biol Blood Marrow Transplant. 2014; 20(12):1975-81. 10.1016/j.bbmt.2014.08.013434320325263628Search in Google Scholar